Trial no.:
|
PACTR202010685660957 |
Date of Approval:
|
19/10/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
KINETIC CONTROL VERSUS MULLIGAN’S MOBILISATION ON FUNCTIONAL OUTCOMES IN PATIENTS WITH LUMBER RADICULOPATHY |
Official scientific title |
KINETIC CONTROL VERSUS MULLIGAN’S MOBILISATION ON FUNCTIONAL OUTCOMES, RANGE OF MOTION, AND PAIN IN PATIENTS WITH LUMBER RADICULOPATHY |
Brief summary describing the background
and objectives of the trial
|
Low back pain (LBP) is one of the most common causes of disability among the general population. Approximately 50%–80% of adults are affected at some time during their lives. It is a leading cause of disability and work loss (Park et al., 2014).
Low back pain is arguably the most prevalent musculoskeletal condition found among both developed and developing nations (Manchikanti, 2000; Hoy et al., 2010; Hoy et al., 2012 and Froud et al., 2014). It is defined as pain and discomfort of varying duration. It is localized below the costal margin and above the inferior gluteal folds, with or without irradiation in the lower limb (Van Tulder et al., 2006).There is evidence that persisting LBP influences lumbar motor control (Luomajoki et al., 2008), decreases spinal mobility (Hodges et al., 2009) and compromises postural control (Mok et al., 2010). The kinetic control is the movement performed with optimum interaction between neuromuscular control (sensory feedback, central nervous system processing and motor coordination) and physiological stresses (Comerford and Mottram 2012). Brian Mulligan introduced techniques known as: spinal mobilization with limb movements (SMWLMs) . Here, a sustained transverse glide is applied to the spinous process of a vertebra while the restricted peripheral upper or lower limb movement is performed, actively or passively.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
LBP |
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
24/09/2020 |
Actual trial start date |
24/09/2020 |
Anticipated date of last follow up |
24/11/2020 |
Actual Last follow-up date |
24/11/2020 |
Anticipated target sample size (number of participants) |
30 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|